ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975

Beckman Coulter Offers Immunoassay System.

July 27, 2001

In Brief: Maguire Wants Five Environmental Experts In Addition To Those On The Board

February 16, 1979

Tobacco Council Announces 11 New Grant Awards

January 24, 1975

Mammography: Panel Member Quits Over “One-Sided” Document

February 14, 1997

In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute

October 31, 2014